- Home
- OSUR vs OABI Comparison
OSUR vs OABI Comparison
Compare OSUR & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- OABI
- Stock Information
- Founded
- OSUR 2000
- OABI 2012
- Country
- OSUR United States
- OABI United States
- Employees
- OSUR N/A
- OABI N/A
- Industry
- OSUR Medical/Dental Instruments
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- OABI Health Care
- Exchange
- OSUR Nasdaq
- OABI Nasdaq
- Market Cap
- OSUR 228.1M
- OABI 236.1M
- IPO Year
- OSUR 1986
- OABI N/A
- Fundamental
- Price
- OSUR $3.20
- OABI $1.94
- Analyst Decision
- OSUR Hold
- OABI Strong Buy
- Analyst Count
- OSUR 1
- OABI 3
- Target Price
- OSUR $3.00
- OABI $7.00
- AVG Volume (30 Days)
- OSUR 811.4K
- OABI 643.9K
- Earning Date
- OSUR 08-05-2025
- OABI 08-06-2025
- Dividend Yield
- OSUR N/A
- OABI N/A
- EPS Growth
- OSUR N/A
- OABI N/A
- EPS
- OSUR N/A
- OABI N/A
- Revenue
- OSUR $161,626,000.00
- OABI $26,744,000.00
- Revenue This Year
- OSUR N/A
- OABI N/A
- Revenue Next Year
- OSUR $6.80
- OABI $45.02
- P/E Ratio
- OSUR N/A
- OABI N/A
- Revenue Growth
- OSUR N/A
- OABI 27.07
- 52 Week Low
- OSUR $2.36
- OABI $1.22
- 52 Week High
- OSUR $4.92
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- OSUR 61.40
- OABI 57.48
- Support Level
- OSUR $3.01
- OABI $1.93
- Resistance Level
- OSUR $3.82
- OABI $2.11
- Average True Range (ATR)
- OSUR 0.17
- OABI 0.14
- MACD
- OSUR 0.02
- OABI -0.00
- Stochastic Oscillator
- OSUR 31.11
- OABI 47.24
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.